Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Aug 27;7(5Part B):832-834.
doi: 10.1016/j.ijwd.2021.08.010. eCollection 2021 Dec.

Treatment of severe psoriasis during pregnancy and breastfeeding: A therapeutic challenging case

Affiliations
Case Reports

Treatment of severe psoriasis during pregnancy and breastfeeding: A therapeutic challenging case

Maria Esposito et al. Int J Womens Dermatol. .
No abstract available

Keywords: Anti-TNF; biologics; certolizumab pegol; pregnancy; psoriasis.

PubMed Disclaimer

Figures

Fig 1
Fig. 1
(A, D) Intensely erythematous confluent psoriasis plaques involving the trunk and extremities at baseline. (B, E) Consistent clinical improvement after certolizumab treatment at week 8 (32nd week of gestation) and (C, F) week 96.

References

    1. Clowse ME, Förger F, Hwang C, Thorp J, Dolhain RJ, van Tubergen A, et al. Minimal to no transfer of certolizumab pegol into breast milk: Results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study. Ann Rheum Dis. 2017;76(11):1890–1896. - PMC - PubMed
    1. Gottlieb AB, Ryan C, Murase JE. Clinical considerations for the management of psoriasis in women. Int J Womens Dermatol. 2019;5(3):141–150. - PMC - PubMed
    1. Lambe M, Bergstrom AV, Johansson ALV, Weibull CE. Reproductive patterns and maternal and pregnancy outcomes in women with psoriasis-A population-based study. J Am Acad Dermatol. 2020;82(5):1109–1116. - PubMed
    1. Mariette X, Förger F, Abraham B, Flynn AD, Moltó A, Flipo RM, et al. Lack of placental transfer of certolizumab pegol during pregnancy: Results from CRIB, a prospective, postmarketing, pharmacokinetic study. Ann Rheum Dis. 2018;77(2):228–233. - PMC - PubMed
    1. Porter ML, Lockwood SJ, Kimball AB. Update on biologic safety for patients with psoriasis during pregnancy. Int J Womens Dermatol. 2017;3(1):21–25. - PMC - PubMed

Publication types